Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eileen Harder, M.D.

Concepts (86)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypertension, Pulmonary4202415531.500 Why?
Radiation Pneumonitis320161031.100 Why?
Radiosurgery6201713351.030 Why?
Idiopathic Interstitial Pneumonias12024240.940 Why?
Prostaglandins I12020130.740 Why?
Phosphodiesterase 5 Inhibitors120201030.680 Why?
Mediastinum120212650.680 Why?
Telangiectasia, Hereditary Hemorrhagic120191400.560 Why?
Esophagitis120171640.540 Why?
Probability1201824770.430 Why?
Pulmonary Embolism3202425150.410 Why?
Vascular Diseases1202111770.410 Why?
Lung Neoplasms62017131730.370 Why?
Lung Diseases1202118990.360 Why?
Radiation Injuries1201711800.350 Why?
Hospitalization22019106280.330 Why?
Venous Thrombosis1201812780.330 Why?
Angiotensin-Converting Enzyme Inhibitors1201515150.310 Why?
Hospital Mortality2201953700.310 Why?
Heart1202143740.290 Why?
Radiotherapy Dosage5201729060.290 Why?
Heart Diseases1201927900.280 Why?
Diagnostic Imaging1202135090.270 Why?
Hemorrhage1201835700.270 Why?
Lung2202498990.270 Why?
Carcinoma, Non-Small-Cell Lung4201652150.250 Why?
Pulmonary Wedge Pressure120242710.210 Why?
Epoprostenol120202490.170 Why?
Pulmonary Artery2202119260.130 Why?
Ventricular Dysfunction, Right120216150.130 Why?
Dose-Response Relationship, Radiation120178730.130 Why?
Lung Volume Measurements120163750.120 Why?
Aged1120241667050.120 Why?
Hemodynamics1202441730.110 Why?
Tumor Burden2201618750.110 Why?
Lung Diseases, Interstitial120208810.100 Why?
Retrospective Studies82024791600.100 Why?
Antihypertensive Agents1202020370.090 Why?
Humans1620247528100.090 Why?
Heart Ventricles1202138030.080 Why?
Cost of Illness1201919110.080 Why?
Blood Pressure1202484680.080 Why?
Risk1201996130.070 Why?
Inpatients1201925600.070 Why?
Male1020243551600.070 Why?
Female1020243863390.070 Why?
Pulmonary Disease, Chronic Obstructive1202031460.060 Why?
Sepsis1201925900.060 Why?
Venous Thromboembolism1201818220.060 Why?
Severity of Illness Index22021156950.060 Why?
Comorbidity12019104750.060 Why?
Follow-Up Studies42021390890.060 Why?
Neoplasm Staging22016110670.060 Why?
Risk Assessment22024237850.060 Why?
Randomized Controlled Trials as Topic12020102000.060 Why?
Odds Ratio1201697010.060 Why?
Middle Aged620242172500.050 Why?
Multivariate Analysis12016121380.050 Why?
Acute Disease2202472170.050 Why?
Prevalence12019155050.050 Why?
Logistic Models12016132770.050 Why?
Prognosis22021293690.040 Why?
Risk Factors22016734180.040 Why?
Tomography, X-Ray Computed12021203500.040 Why?
Time Factors12019398850.040 Why?
Cross-Sectional Studies12019255400.040 Why?
Neoplasm Recurrence, Local1201592070.030 Why?
United States32021714340.030 Why?
Respiratory Function Tests1202116690.030 Why?
Survival120161610.030 Why?
Pulmonary Veins120217320.030 Why?
Relative Biological Effectiveness120163210.030 Why?
Survival Rate22021127510.030 Why?
Four-Dimensional Computed Tomography120151480.030 Why?
Adult320242171680.030 Why?
Prospective Studies12015538330.020 Why?
Propensity Score1201618720.020 Why?
Echocardiography1202149490.020 Why?
Dyspnea1201513470.020 Why?
Linear Models1201658580.020 Why?
Kaplan-Meier Estimate1201665030.020 Why?
Survival Analysis12016101870.010 Why?
Proportional Hazards Models12016124550.010 Why?
Sensitivity and Specificity12016146010.010 Why?
Aged, 80 and over12016583470.010 Why?
Treatment Outcome12016642880.010 Why?
Harder's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (86)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.